HomeVALIANTLAB • NSE
add
Valiant Laboratories Ltd
Previous close
₹107.04
Day range
₹106.05 - ₹107.90
Year range
₹75.20 - ₹157.49
Market cap
4.65B INR
Avg Volume
39.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 577.86M | 88.92% |
Operating expense | 62.52M | 83.52% |
Net income | 7.04M | 156.77% |
Net profit margin | 1.22 | 130.12% |
Earnings per share | — | — |
EBITDA | 38.31M | 183.19% |
Effective tax rate | 25.07% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 759.91M | -47.16% |
Total assets | 4.01B | 16.97% |
Total liabilities | 1.67B | 57.38% |
Total equity | 2.34B | — |
Shares outstanding | 43.98M | — |
Price to book | 2.01 | — |
Return on assets | — | — |
Return on capital | 2.35% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 7.04M | 156.77% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1980
Website
Employees
77
